Alexion Pharmaceuticals MBA Summer Internship - US Marketing Metabolics in Boston, Massachusetts
This position is a paid, 10-week summer marketing internship based at our new Boston, MA headquarters. You will be responsible for projects that may include analytics, market research, patient and physician education, as well as print and digital marketing. This internship will include training on the disease and Alexion’s approved treatment. As a Summer Marketing Intern, you will also gain an understanding of the business as a whole and interact with cross-functional teams, including US Sales, Customer Operations, Diagnostics, Market Access, and Medical.
Completed Bachelor’s degree and a current full-time MBA candidate scheduled to graduate in May 2019
Proven ability to coordinate and implement multiple projects simultaneously
Proven teamwork and collaboration skills
Persuasive written and verbal communication skills
Ability to manage and deliver projects on time and within budget
Ability to quickly understand and communicate clinical data/publications to support business objectives
Ability to solve problems that include multiple decision makers and carry several options for solutions
Compliance with Alexion internal processes regarding legal, regulatory, and financial policies and procedures
Authorization to work in the US
- Sales, marketing, healthcare, consulting, not-for-profit
Some opportunities happen only once in a lifetime – like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a multinational biopharmaceutical company with approximately 2,500 dedicated employees serving patients in more than 50 countries through the innovation, development, and commercialization of life-changing therapies. As the global leader in complement biology, Alexion developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). Our research efforts focus on novel molecules and targets in the complement cascade, and our development efforts focus on our core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders.
Alexion’s aspiration is to be the most rewarding place to work, where people are empowered to make a difference and where diversity of backgrounds and ideas is encouraged. We are looking for talented individuals who share our passion and commitment to change the lives of patients with rare diseases. We hope you will consider joining our team.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Alexion, please visit www.alexion.com.
Alexion is an Equal Opportunity /Affirmative action employer